Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Allamand

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Human Molecular Genetics|September 27, 2000
Animal models for muscular dystrophy: valuable tools for the development of therapiesV Allamand, K P Campbell
Human Heredity|July 1, 1997
Mapping using linkage disequilibrium estimates: a comparative studyV Allamand, J S Beckmann
Neuromuscular Disorders : NMD|March 8, 2016
212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015M Saunier, C G Bönnemann, M Durbeej, et al.
Human Heredity|November 14, 1998
Limb girdle muscular dystrophy type 2A (CAPN3): mapping using allelic associationC Lonjou, A Collins, J Beckmann, et al.
European Journal of Human Genetics : EJHG|January 1, 1994
The EUROGEM map of human chromosome 12A Bosch, I Banchs, A Puig, et al.
Human Molecular Genetics|February 1, 1994
Three dinucleotide markers on chromosome 21A P de Souza, V Allamand, I Richard, et al.
Human Molecular Genetics|February 1, 1994
Dinucleotide repeat polymorphism at D15S221V Allamand, A P de Souza, I Richard, et al.
Human Molecular Genetics|February 1, 1994
Two dinucleotide repeats tightly linked to D12S91A P de Souza, V Allamand, I Richard, et al.
Gene Therapy|February 20, 2004
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatmentL Bidou, I Hatin, N Perez, et al.
Gene Therapy|September 12, 2000
Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient miceV Allamand, K M Donahue, V Straub, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|September 27, 2000
Animal models for muscular dystrophy: valuable tools for the development of therapiesV Allamand, K P Campbell
Human Heredity|July 1, 1997
Mapping using linkage disequilibrium estimates: a comparative studyV Allamand, J S Beckmann
Neuromuscular Disorders : NMD|March 8, 2016
212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015M Saunier, C G Bönnemann, M Durbeej, et al.
Human Heredity|November 14, 1998
Limb girdle muscular dystrophy type 2A (CAPN3): mapping using allelic associationC Lonjou, A Collins, J Beckmann, et al.
European Journal of Human Genetics : EJHG|January 1, 1994
The EUROGEM map of human chromosome 12A Bosch, I Banchs, A Puig, et al.
Human Molecular Genetics|February 1, 1994
Three dinucleotide markers on chromosome 21A P de Souza, V Allamand, I Richard, et al.
Human Molecular Genetics|February 1, 1994
Dinucleotide repeat polymorphism at D15S221V Allamand, A P de Souza, I Richard, et al.
Human Molecular Genetics|February 1, 1994
Two dinucleotide repeats tightly linked to D12S91A P de Souza, V Allamand, I Richard, et al.
Gene Therapy|February 20, 2004
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatmentL Bidou, I Hatin, N Perez, et al.
Gene Therapy|September 12, 2000
Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient miceV Allamand, K M Donahue, V Straub, et al.
Pageof 4